caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1730161050

Jason BarkerMD

PRACTICEUIHC UROLOGY CLINICSee all providers at this practice →
Infectious DiseaseIowa City, IAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Jason Barker's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
STATE UNIVERSITY OF IOWA86218
Donald Brown
Internal Medicine · Iowa City, IA
2850
NPI 14775387672548
Bruno Policeni
Diagnostic Radiology · Iowa City, IA
1740
Brian Mullan
Diagnostic Radiology · Iowa City, IA
1327
Michael Giudici
Clinical Cardiac Electrophysiology · Mason City, IA
1116
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
123
Unique beneficiaries
—
Total services
162
Distinct HCPCS
5
Medicare payment
$12K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 47 Infectious Disease providers in IA — below median (cohort median 474).
PRESCRIBING · PART D · 2024
Total Rx claims
779
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
34
Brand share
52.1%
Top prescribed drugs
Atorvastatin Calcium80 claims
Emtricitabine/Tenofov Alafenam59 claims
Abacavir/Dolutegravir/Lamivudi49 claims
Amlodipine Besylate44 claims
Dolutegravir Sodium/Lamivudine42 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
80.0
Quality
75.7
Cost
72.3
Improvement activities
40.0
Promoting interop.
78.0
Payment adjustment
0.21%
Group